Haarr Marianne Bore, Lindbäck Emil, Håland Torfinn, Sydnes Magne O
Faculty of Science and Technology, Department of Mathematics and Natural Sciences, University of Stavanger, NO-4036 Stavanger, Norway.
GE Healthcare AS, NO-4521 Lindesnes, Norway.
ACS Omega. 2018 Jul 5;3(7):7344-7349. doi: 10.1021/acsomega.8b00411. eCollection 2018 Jul 31.
, -Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(-(oxiran-2-ylmethyl)acetamido)isophthalamide (), the alleged precursor of several minor byproducts formed when the X-ray contrast agent iodixanol is synthesized from 5-acetamido- , -bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide (), has been successfully prepared with an overall yield of 25%. Epoxide enabled the confirmation of its presence in the reaction mixture during the preparation of iodixanol when amide was used as the starting material.
1,3 - 双(2,3 - 二羟基丙基)-2,4,6 - 三碘 - 5 - [N - (环氧乙烷 - 2 - 基甲基)乙酰胺基]间苯二甲酰胺( ),据称是在由5 - 乙酰胺基 - 1,3 - 双(2,3 - 二羟基丙基)-2,4,6 - 三碘间苯二甲酰胺( )合成X射线造影剂碘克沙醇时形成的几种次要副产物的前体,已成功制备,总产率为25%。环氧化物 能够在以酰胺 为起始原料制备碘克沙醇的过程中确认其在反应混合物中的存在。